Sight Sciences, Inc. (SGHT) Financial Statements (2025 and earlier)

Company Profile

Business Address 4040 CAMPBELL AVE,
MENLO PARK, CA 94025
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments138,129185,000260,687
Cash and cash equivalent138,129185,000260,687
Receivables14,28915,1488,709
Inventory, net of allowances, customer advances and progress billings7,8496,1143,475
Inventory7,8496,1143,475
Other undisclosed current assets2,6043,4154,164
Total current assets:162,871209,677277,035
Noncurrent Assets
Operating lease, right-of-use asset1,4581,6141,495
Property, plant and equipment1,6401,5711,454
Other noncurrent assets682211202
Total noncurrent assets:3,7803,3963,151
TOTAL ASSETS:166,651213,073280,186
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities3,3707,99512,339
Interest and dividends payable275
Employee-related liabilities5,987
Accounts payable1,7312,6883,351
Accrued liabilities1,6395,3072,726
Other undisclosed current liabilities8,8829,8221,165
Total current liabilities:12,25217,81713,504
Noncurrent Liabilities
Long-term debt and lease obligation31,70833,31332,656
Long-term debt, excluding current maturities31,70833,31332,656
Liabilities, other than long-term debt2,4761,8671,919
Other liabilities2,4761,8671,919
Total noncurrent liabilities:34,18435,18034,575
Total liabilities:46,43652,99748,079
Equity
Equity, attributable to parent120,215160,076232,107
Common stock494848
Additional paid in capital414,956399,271385,060
Accumulated deficit(294,790)(239,243)(153,001)
Total equity:120,215160,076232,107
TOTAL LIABILITIES AND EQUITY:166,651213,073280,186

Income Statement (P&L) ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenues81,05671,33148,956
Cost of revenue
(Cost of Product and Service Sold)
(11,881)(12,361)(8,610)
Gross profit:69,17558,97040,346
Operating expenses(126,449)(142,924)(91,824)
Operating loss:(57,274)(83,954)(51,478)
Nonoperating income (expense)7,2452,225(6,928)
Investment income, nonoperating   
Other nonoperating income (expense)7,2452,225(6,928)
Interest and debt expense(5,408)(4,466)(4,366)
Loss from continuing operations before equity method investments, income taxes:(55,437)(86,195)(62,772)
Other undisclosed loss from continuing operations before income taxes   
Loss from continuing operations before income taxes:(55,437)(86,195)(62,772)
Income tax expense(110)(47)(188)
Loss from continuing operations:(55,547)(86,242)(62,960)
Loss before gain (loss) on sale of properties:(62,960)
Net loss available to common stockholders, diluted:(55,547)(86,242)(62,960)

Comprehensive Income ($ in thousands)

12/31/2024
12/31/2023
12/31/2022
12/31/2021
Net loss:(55,547)(86,242)(62,960)
Comprehensive loss, net of tax, attributable to parent:(55,547)(86,242)(62,960)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: